Search Ontology:
ChEBI
empagliflozin
- Term ID
- CHEBI:82720
- Synonyms
-
- (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol
- (1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucitol
- 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene
- BI 10773
- BI-10773
- BI10773
- empagliflozin
- JARDIANCE
- Definition
- A C-glycosyl compound consisting of a beta-glucosyl residue having a (4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl group at the anomeric centre. A sodium-glucose co-transporter 2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- References
-
- CAS:864070-44-0
- Drug_Central:4830
- KEGG:D10459
- PMID:23859488
- PMID:23859534
- PMID:23906415
- PMID:24226524
- PMID:24491572
- PMID:24716752
- PMID:24722494
- PMID:24746173
- PMID:24766495
- PMID:24795251
- PMID:24929430
- PMID:24944269
- PMID:24948511
- PMID:24958326
- PMID:24964723
- PMID:24991224
- PMID:24993361
- PMID:25061325
- PMID:25161155
- PMID:25199997
- PMID:25260362
- PMID:25271206
- PMID:25274537
- PMID:25296258
- PMID:25301180
- Reaxys:12378768
- Wikipedia:Empagliflozin
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from empagliflozin
Phenotype where environments contain empagliflozin
Phenotype modified by environments containing empagliflozin
Human Disease / Model Data